Smith, Moore & Co.
- SEC CIK
- 0000200724
- Latest filing
- Aug 12, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −2,933−100.0% | Sold out | Holders |
| Q2 2025 | 2,933 | $202.4K | <0.1% | +2,933 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −2,761−100.0% | Sold out | Holders |
| Q3 2024 | 2,761 | $328.8K | <0.1% | −1,338−32.6% | Reduced | Holders |
| Q2 2024 | 4,099 | $585.1K | 0.1% | +184+4.7% | Added | Holders |
| Q1 2024 | 3,915 | $502.7K | 0.1% | +215+5.8% | Added | Holders |
| Q4 2023 | 3,700 | $382.8K | <0.1% | +700+23.3% | Added | Holders |
| Q3 2023 | 3,000 | $272.8K | <0.1% | +3,000 | New | Holders |